The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: Primary vs metastatic

Annals of Diagnostic Pathology

Volumn 19, Issue 4, 2015, Pages 249-252

  Perez Montiel, Delia ^a   Arispe Angulo, Karen ^a   Cantú De León, David ^a   Bornstein Quevedo, Leticia ^b   Chanona Vilchis, José ^a   Herrera Montalvo, Luis ^c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b Universidad   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Colon; Metastasis; Mucinous ovarian tumors; SATB2

Indexed keywords

CK20 PROTEIN; EOSIN; HEMATOXYLIN; PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 2; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; CDX2 PROTEIN, HUMAN; CYTOKERATIN 20; HOMEODOMAIN PROTEIN; KRT20 PROTEIN, HUMAN; MATRIX ATTACHMENT REGION BINDING PROTEIN; SATB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILATERAL CANCER; CANCER GROWTH; COLLOID CARCINOMA; COLON CANCER; COLON METASTASIS; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GALLBLADDER CANCER; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS OVARIAN TUMOR; OVARY METASTASIS; OVARY TERATOMA; OVARY TUMOR; PANCREAS METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; UTERINE CERVIX CANCER; VERY ELDERLY; ADENOCARCINOMA, MUCINOUS; COLONIC NEOPLASMS; METABOLISM; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; SECONDARY; TERATOMA;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; BIOMARKERS, TUMOR; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; TERATOMA; TRANSCRIPTION FACTORS;

EID: 84937518063     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2015.05.004     Document Type: Article

References (14)

1. R.J. Zaino, M.F. Brady, S.M. Lele, and et al. Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study Cancer 117 2011 554 562
2. K.R. Lee, and R.H. Young The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases Am J Surg Pathol 27 2003 281 292
3. R.A. Soslow Mucinous ovarian carcinoma: slippery business Cancer 117 2011 451 453
4. P.B. Pinto, S.F. Derchain, and L.A. Andrade Metastatic mucinous carcinoma in the ovary: a practical approach to diagnosis to gross aspects and to immunohistochemical evaluation Int J Gynecol Pathol 31 2012 313 318
5. A.D. Tabrizi, S.E. Kalloger, M. Köbel, and et al. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol 29 2010 99 107
6. P.J. Zhang, M. Shah, G.V. Spiegel, and et al. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas Appl Immunohistochem Mol Morphol 11 2003 306 310
7. M. Redston Epithelial neoplasms of the large intestine R. Odze, J.R. Goldblum, Surgical pathology of the GI tract, liver, biliary tract and pancreas 2009 Saunders Philadelphia 597 637
8. R. Vang, A.M. Gown, L.S. Wu, and et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinoma involving the ovary: comparison with CK20, and correlation with coordinate expression of CK7 Mod Pathol 19 2006 1421 1428
9. R.W. Werling, H. Yaziji, C.E. Bachi, and et al. CDX2, a highly sensitive and specific marker of adenocarcinoma of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinoma Am J Surg Pathol 27 2003 303 310
10. K. Magnusson, M. de Wit, D.J. Brennan, and et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas Am J Surg Pathol 35 2011 937 948
11. T.M. Ulbright, L.M. Roth, and F.B. Stehman Secondary ovarian neoplasia. A clinicopathologic study of 35 cases Cancer 53 1984 1164 1174
12. M.F. Lerwill, and R.H. Young Metastatic tumors of the ovary R.J. Kurman, L.H. Ellenson, B.M. Ronnett, Blausteińs pathology of the female genital tract 2011 Springer Science Berlin 930 997
13. N.G. Ordóñez SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma Adv Anat Pathol 21 2014 63 67
14. R. Vang, A.M. Gown, C. Zhao, and et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary Am J Surg Pathol 31 2007 854 869